<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Roundup: Biogenerics bill in limbo, clashing data on health IT benefits, the RNAi boom, and more</title>
	<atom:link href="http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 13:10:56 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; New biotech startup Excaliard Pharma raises $16M for a fresh stab at antisense drugs</title>
		<link>http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/comment-page-1/#comment-653550</link>
		<dc:creator>VentureBeat &#187; New biotech startup Excaliard Pharma raises $16M for a fresh stab at antisense drugs</dc:creator>
		<pubDate>Wed, 28 Nov 2007 03:09:15 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/#comment-653550</guid>
		<description>[...] that aim to shut down disease-related genes have long been out of favor, and these days live in the shadow of a hotter and newer technology &#8212; RNA interference &#8212; that does much the same thing. But that hasn&#8217;t stopped [...]</description>
		<content:encoded><![CDATA[<p>[...] that aim to shut down disease-related genes have long been out of favor, and these days live in the shadow of a hotter and newer technology &#8212; RNA interference &#8212; that does much the same thing. But that hasn&#8217;t stopped [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 31, 2007</title>
		<link>http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/comment-page-1/#comment-607056</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 31, 2007</dc:creator>
		<pubDate>Wed, 31 Oct 2007 17:34:02 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/07/12/roundup-biogenerics-bill-in-limbo-clashing-data-on-health-it-benefits-the-rnai-boom-and-more/#comment-607056</guid>
		<description>[...] a lot of money has been sloshing around the field recently (see our coverage in the third item here), and there&#8217;s little doubt that deep-pocketed folks still on the sidelines will want to at [...]</description>
		<content:encoded><![CDATA[<p>[...] a lot of money has been sloshing around the field recently (see our coverage in the third item here), and there&#8217;s little doubt that deep-pocketed folks still on the sidelines will want to at [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
